Ho-ho-ho! Gather ’round, my curious elves, for a tale of medical marvels and the quest to outwit the brain’s own frosty fortress—the blood-brain barrier (BBB). In the wintry realm of primary brain tumors, there’s been a flurry of activity over the past five jolly years to find ways to sneak past this barrier, much like I slip down chimneys on Christmas Eve.

The most popular sleigh for this journey has been mannitol, a sweet little sugar that, when used in a magical concoction, can gently open the gates of the BBB. This has been a gift to the superselective intra-arterial cerebral infusion (SIACI)—a technique as precise as an elf’s craftsmanship—allowing chemotherapeutics to tiptoe directly to where they’re needed.

But wait, there’s more in Santa’s sack! Convection-enhanced delivery has been like finding a new reindeer route, bypassing the BBB altogether to deliver therapeutic goodies straight to the tumor’s doorstep. And let’s not forget the shiny new toys: laser interstitial thermal therapy (LITT) and focused ultrasound (FUS). These bright stars have emerged as the Rudolphs of treatment, guiding the way to directly target tumors and cause a merry disruption in the BBB.

In this winter wonderland of scientific discovery, the excitement has been snowballing. Researchers have been as busy as elves in a toy workshop, studying these modalities to disrupt the BBB in primary brain tumors. Their goal? To enhance treatment responses and bring about better clinical outcomes, spreading hope and joy much like the spirit of Christmas. So, let’s jingle all the way to a future where brain tumors are but a ghost of Christmas past. 🎅🎄